| 中文名称 | 他尼氟酯 |
| 英文名称 | Talniflumate |
| CAS号 | 66898-62-2 |
| 分子式 | C21H13F3N2O4 |
| 分子量 | 414.33 |
| EINECS号 | 1533716-785-6 |
| 熔点 | 165-167°C |
| 沸点 | 534.6±50.0 °C(Predicted) |
| 密度 | 1.49±0.1 g/cm3(Predicted) |
| 溶解度 | 可溶于氯仿(轻微)、DMSO(轻微)、甲醇(轻微) |
| 形态 | 固体 |
| 酸度系数(pKa) | 2.72±0.10(Predicted) |
| 颜色 | 灰白色至浅黄色 |
| 最大波长(λmax) | 287nm(CHCl3)(lit.) |
| 默克索引编号 | 14,9044 |
| 稳定性 | 对酸敏感,对湿气敏感 |
| RTECS号 | QT2999200 |
| 海关编码 | 2933.39.9200 |
| 毒性 | LD50 orally in rats: 12000 mg/kg (Los) |
IC50: Ca 2+ -activated Cl - channel (CaCC)
Talniflumate (oral chow; 0.4 mg/g; 21 days) significantly increases CF mouse survival from 26 to 77%. It does not alter crypt goblet cell numbers or change intestinal expression of mCLCA3 but tends to decrease crypt mucoid impaction.
| Animal Model: | CF mice with distal intestinal obstructive syndrome (DIOS) |
| Dosage: | 0.4 mg/g |
| Administration: | Oral chow; 21 days |
| Result: | Increased survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome. |
他尼氟酯为非甾体消炎镇痛原料药,同时可用于纤维性囊肿和哮喘的辅助治疗。